ESTIMATION OF HOSPITAL STAY TIME FOR CA-THYROID PATIENTS TREATED WITH RADIOIODINE-131 By Sudipta Saha 1 Dr. Ashoke kumar paul 2 Dr. M. Shakilur rahman.

Slides:



Advertisements
Similar presentations
Written Directive “an authorized user’s written order for the administration of byproduct* material or radiation from by product material to a specific.
Advertisements

Iodine-131 Therapy and the Dialysis Patient M.J. Bohan and R.L. Richardson Yale-New Haven Hospital Radiation Safety Office.
Frank P. Dawry.
The Surgical Completeness of Robotic thyroidectomy : A prospective Comparative Study of Robotic versus conventional open thyroidectomy in papillary thyroid.
IAEA International Atomic Energy Agency Responsibility for Radiation Safety Day 8 – Lecture 4.
Copyright © 2012, 2011, 2010, 2009, 2008, 2007, 2006, 2005, 2004, 2002 by Saunders, an imprint of Elsevier Inc. Slide 1 CHAPTER 31 INPATIENT CODING.
Clinical Trials Medical Interventions
Establishment of a Training Dosimetry Laboratory in Cairo University Dr. Hassan Fathy for NSPA.
School for drafting regulations Nuclear Safety Decommissioning Vienna, 2-7 December 2012 Tea Bilic Zabric.
INTRODUCTION TO ICD-9-CM PART TWO ICD-9-CM Official Guidelines (Sections II and III): Selection of Principal Diagnosis/Additional Diagnoses for Inpatient.
Clinical Trials The Way We Make Progress Against Disease.
Radioiodine Therapy for Graves’ Disease Dr. Khalid B. Makhdomi Nuclear Medicine Physician Aga Khan University Hospital, Nairobi.
® Introduction Low Back Pain Remedies and Procedures: Helpful or Harmful? Lauren Lyons, Terrell Benold, MD, Sandra Burge, PhD The University of Texas Health.
Intra-Operative Radiation Therapy for Treatment of Early Stage Breast Cancer: Short Term Results from a Single Institution Clinical Trial Using Electronic.
1.Royal College of Obstetricians and Gynaecologists. The Green Top Guidelines Number 21: The management of tubal pregnancy. (Online). Available from:
Levothyroxine Suppressive Therapy in Thyroid Cancer R Michael Tuttle, MD Attending Endocrinologist Assistant Professor of Medicine Memorial Sloan Kettering.
Introduction to Nuclear Medicine
Status of Radiation Protection in Bangladesh
Clinical Trials. What is a clinical trial? Clinical trials are research studies involving people Used to find better ways to prevent, detect, and treat.
Approach to a thyroid nodule
Testing People Scientifically.  Clinical trials are research studies in which people help doctors and researchers find ways to improve health care. Each.
Role of Biomarkers in Management of Prostate Cancer Dr. Angela Amayo Specialist Pathologist 13 th April 2012.
Investigational Drugs in the hospital. + What is Investigational Drug? Investigational or experimental drugs are new drugs that have not yet been approved.
Prepared By : Miss. Sana’a AL-Sulami Teacher Assistant.
Corticosteroid dosing in the treatment of acute exacerbations of COPD Kurt A. Wargo, Pharm.D., BCPS, Takova D. Wallace, Pharm.D. Candidate 2014, Ryan E.
Hot Lab 11. dose calibrator, an ionization chamber used in nuclear medicine to measure the amount of radioactivity of a radionuclide before injection.
Using Radiation in Medicine. There are 3 main uses of radiation in medicine: Treatment Diagnosis Sterilization.
Assembly Bill #2609 Health and Safety Code Effective January 1,2008 MEDICATION TRAINING FOR DIRECT CARE STAFF.
Determination of Effective Half-Life of 131 I in Thyroid Cancer Patients Hoang T. Vu Allen Hrejsa & Alex Markovic *Department of Medical Radiation Physics,
A physician, dentist, or podiatrist who: (1) Meets the requirements in §§ and (a), (a), (a), (a), (a), (a), (a),
® Introduction Changes in Opioid Use for Chronic Low Back Pain: One-Year Followup Roy X. Luo, Tamara Armstrong, PsyD, Sandra K. Burge, PhD The University.
RADIATION SAFETY Mrs. Brinston. Introduction As a healthcare worker, you know that radiation is an important tool for detecting and treating diseases.
The 29th Conference ARAB-ACRAO 29 March - 3 April 2009 Comparison of Student Flow in Different Colleges of Kuwait University Using Absorbing Markov Analysis.
 A test of a new intervention or treatment on people.
 Radiopharmaceuticals are agents used to diagnose certain medical problems or treat certain diseases. They may be given to the patient in several different.
بسم الله الرحمن الرحيم جامعة أم درمان الإسلامية كلية الطب و العلوم الصحية - قسم طب المجتمع مساق البحث العلمي / الدفعة 21 Basics of Clinical Trials.
Application of Calibrated Instruments in Medical Facilities MAJ H. Mike Stewart, Jr., MS, CHP April 17, 2009.
HIT FINAL EXAM REVIEW HI120.
بسم الله الرحمن الرحيم. Adult Hodgkin’s Lymphoma in the Eastern Part of Libya Dr. M.Mangoush, R. Nafo, S.Kardah, M.Letaiwish, S.Kardah, F.Bodabous, S.Ebkhatra.
ASSESSING THE FEASIBILITY OF ANTIBIOTIC MANAGEMENT SERVICES THROUGH PROSPECTIVE EVALUATION ABSTRACT PURPOSE: The inappropriate and unnecessary use of antibiotics.
Introduction to nuclear medicine technology NMT 231 Aya Ahmed Saeed.
Prince of Wales Hospital Patient Satisfaction Survey April – June 2015.
CHSP and CalHEN Opioid Adverse Drug Event Prevention Gap Analysis: Survey Findings August 14, 2013, 2013.
Outlines At the completion of this lecture the student will be able to identify the concept and related terms of: Infection- Infection control-
1. Clinical Impression? Differentials?. Thyroid Carcinoma commonly manifests as a painless, palpable, solitary thyroid nodule The patient's age at presentation.
VIII.3. Optimization of Protection for Medical Exposures in Nuclear Medicine. 4. Guidance levels Postgraduate Educational Course in Radiation Protection.
Organization and Implementation of a National Regulatory Program for the Control of Radiation Sources Technical Services.
Regularly Scheduled Artificial (IV) Hydration among Head and Neck Cancer Patients Undergoing Radiotherapy-based Treatment By Jessica Mooney With special.
 Define Survivorship  Demonstrate understanding of the history of cancer survivorship  State the requirements of the Commission on Cancer of the American.
Measurement Technique A technique was developed for measuring the radioactive concentration of breast milk samples for Tc-99m labelled radiopharmaceuticals.
COUNTRY REPORT: PHILIPPINES Dr. Miriam Joy C. Calaguas.
Iodine 131 Medical Uses.
Introduction Your role Communicating risk Conclusions Radiation risks.
231 Unusual coexistence of differentiated thyroid cancer and thyrotropin- producing pituitary microadenoma: a case report 1 Muni A., 1 Rouhanifar H., 1.
Current status of medical physicist certification in Poland and neighbouring regions. Julian Malicki University of Medical Sciences Greater Poland Cancer.
Pneumocystis pneumonia mimicking Lung metastasis in a HIV- Positive Patient with Metastatic Follicular Thyroid Cancer Dr ZM Jawa MBBS, MSc, FMCR, FCNP,
The environmental dose measurements of high dose Iodine-131 treated thyroid cancer patients during hospitalization period Nina TUNÇEL  Department of Physics,
Date of download: 10/7/2017 Copyright © ASME. All rights reserved.
Radiation related Procedures and in-Utero Effects
Transposition of Requirements set out in the Basic Safety Standards for Nuclear Facilities in Lithuania Gintautas KLEVINSKAS Albinas MASTAUSKAS Radiation.
A study of certain sociodemographic factors among patients with dog bite in Community Health Centre, Mulky, Dakshina Kannada District, INDIA Dr N UDAYA.
Radio Iodine Therapy In Cancer Thyroid
Professor of Nuclear Medicine Cairo University, Egypt
Maria Belgun, L.Dumitriu, A.Goldstein, Mariana Purice, F.Alexiu
Controlling Measuring Quality of Patient Care
Clinical Trials.
Hospital Antibiotic Stewardship Programs
Communicating With Your Patients About Major Depressive Disorder
National Cancer Center
EXTENT OF CHANGES IN PRE AND POSTDONATION DONOR VARIABLES IN SINGLE AND DOUBLE DOSE PLATELETPHERESIS AND ITS IMPLICATIONS ON DONOR SAFETY Dr. R. Sreedevi.
Presentation transcript:

ESTIMATION OF HOSPITAL STAY TIME FOR CA-THYROID PATIENTS TREATED WITH RADIOIODINE-131 By Sudipta Saha 1 Dr. Ashoke kumar paul 2 Dr. M. Shakilur rahman 1 Dr. Jharna das 2 Dr. Jasmin ferdous 2 1. Institute of Nuclear Science and Technology, AERE, Savar 2. Center for Nuclear Medicine & Ultrasound, Khulna

Introduction Oral administration of radioiodine (I -131) has been a commonly accepted procedure in nuclear medicine for treatment of hyperthyroid, thyrotoxicosis and thyroid carcinoma patients. I -131 as sodium iodide has been used to treat residual cancerous thyroid tissue and metastatic disease after partial or complete thyroidectomy (surgery). The service is also a regular practice in Center for Nuclear Medicine & Ultrasound, Khulna with the facility of indoor cabin of Khulna medical college hospital.

Aim and Objective The study has been carried out - to assess the risk to the environment from these radioactive patients after radioiodine-131 capsule administration. - to re-estimate the time to stay in hospital after post surgery radioiodine therapy procedures for complete thyroid ablation.

Method Type of Study: Prospective Study Place: Center for Nuclear Medicine & Ultrasound, Khulna Khulna Medical College Hospital Study Period:December, 2011 to April, No. of Patients:20 [Twenty] Measuring Tools:Radiation survey meter (Geiger-Muller Counter)

Method (Cont.) According to the suggested procedure by Society of Nuclear Medicine, Bangladesh* the condition to release the patient from hospital is After 7 days with other following steps. or, the survey meter reading at 1 meter distance from patient is 0.2 mrem/h or 2.0µSv/h. One Physicist and one Physician with an expert Scientific personnel are appointed for regular surveillance as well as to take Gamma counts by Radiation survey meter (Geiger-Muller Counters) for dose measurement. * F. Alam, A. S. M. Moinul Islam and M. A. Karim, Bangladesh J. Nucl. Med., 5(2), pp 39 (2002)

Method (Cont.) In the present proceedings, all the patients are categorized in three ways- (a) Sex (b) Surgical Procedure (c) Radioiodine dose received The below table shows the categorized scenario of 20 patients: Table I: SexSurgical ProceduresDose Received MaleFemale Near Total Sub Total Modified neck resection 75 mci 100 mci 150 mci 200 mci Total20

Method (Cont.) The present study is been carried out using the below pictured survey meters. The energy range countable in these survey meters is 0.45 KeV – 2 MeV.

Results In the demonstrated study, total patients were classified into four groups according to their administered activities. P-75 (1-2) = 75 mci capsule administered patients. P-100 (1-14)= 100 mci capsule administered patients. P-150 (1-3)= 150 mci capsule administered patients. P-200-1= 200 mci capsule administered patients.

Results (Cont.) The Table II, III, IV, V show the real picture of decreasing dose rate of radiation at 1 meter distance from patients for 7 days or until the dose decreased below 0.2 mrem/h. The Figures I, II, III, IV are representing the decreasing character of radiation dose from patients graphically.

Results (Cont.) Table II: The doses from patients received 75 mCi. PatientsSurvey counts from 1m distance in µSv/h Just after administration 24 hrs48 hrs72 hrs96 hrs120 hrs144 hrs P P STDEV

Results (Cont.) Figure-1: The graph shows the nature of decrease of radiation dose from patients received 75 mCi. Y-axis is representing the radiation doses in µSv/h with the change according to time in days on X-axis.

PatientsSurvey counts from 1m distance in µSv/h Just after administration 24 hrs48 hrs72 hrs96 hrs120 hrs144 hrs P P P P P P P P P P P P P P STDEV Results (Cont.) Table III: The doses from patients received 100 mCi.

Results (Cont.) Figure-II: The line graph shows nature of decrease of radiation dose from patients received 100 mCi. Y-axis is representing the radiation doses in µSv/h with the change according to time in days on X-axis.

PatientsSurvey counts from 1m distance in µSv/h Just after administration 24 hrs48 hrs72 hrs96 hrs120 hrs144 hrs P P P STDEV Results (Cont.) Table IV: The doses from patients received 150 mCi

Results (Cont.) Figure-III: The line graph shows nature of decrease of radiation dose from patients received 150 mCi. Y-axis is representing the radiation doses in µSv/h with the change according to time in days on X-axis.

PatientsSurvey counts from 1m distance in µSv/h Just after administration 24 hrs48 hrs72 hrs96 hrs120 hrs144 hrs P Results (Cont.) Table V: The doses from patients received 200 mCi Figure-III: In the line graph Y-axis is representing the radiation doses in µSv/h with the change according to time in days on X-axis. of 200 mCi administered patients.

Patient Categories Standard deviation with Time (%) After Administration 24 hrs48 hrs72 hrs96 hrs120 hrs144 hrs P P P Results (Cont.) Table VI: Table of standard deviation calculation with time.

Results (Cont.) According to this guideline 65% of all patients could be released after 96 h as the dose decreased to the required value and the remaining the patients could be released after 120 hrs with maiden exception.

Discussion Study represents, within first 72 hours more than 80% radioiodine has been washed out from the patient body. This time interval after oral administration of therapeutic capsule becomes very important from the point of view of radiation protection. The patient and his/her attendant must be well motivated to follow the written guidelines for lesser contamination.

Discussion (Cont.) In 5 th day the dose decreases to 0.2 mrem/h at 1 meter distance for about 45% patients and near 0.3 mrem/h came from others with one exception. So on the 4 th day and day after, taking the measure of radiation dose the patient can be identified to be released earlier than 7 days.

Discussion (Cont.) Comparing with other guidelines from different countries, considering the socio-economic condition, literacy level, nature of job and family the criteria to release the patient from hospital can be suggested to re- estimate the isolation time duration from seven days to 72 hrs of capsule administration or the dose in radiation survey meter is 4 µSv/h at one meter distance is recorded.

Discussion (Cont.) Advantages of regular monitoring of these patients using survey meter is - Hospital burden of indoor patients can be minimized. - Financial burden of patient and attendants will be minimized.

Conclusion Monitoring of radiation dose during radiation therapy of Ca-thyroid patients is important to assess time limit for discharge of them. Motivation and good communication of patients and measurement of radiation dose using survey meter in hospital admission time may ensure radiation protection to the public as well.

Thank You All